As more investors seek to avoid poor ESG performers from their portfolios, Zenith Investment Partners unpacks the complexities around negative screening. Negative screening can be defined as the ...

One in four colorectal cancer cases, detected through a guiac fecal occult blood testing program, are diagnosed within two years of a negative screening result, according to a study in the UEG Journal ...